ICD-10-CM Billable Code

C43.31

Malignant melanoma of nose

Clinical Classification Guidelines

Medical Intelligence & Overview

Malignant melanoma of the nose is a serious form of skin cancer arising from the pigment-producing cells known as melanocytes. It occurs when these cells undergo malignant transformation, leading to the development of an aggressive tumor on or near the nasal area. Recognized under the ICD-10 code C43.31, this condition requires prompt attention due to its potential to spread and affect other parts of the body. Early detection and treatment are crucial for improving outcomes and survival rates.

Causes & Symptoms

Clinical Causes: Excessive exposure to ultraviolet (UV) radiation from sunlight or tanning beds History of sunburns, especially during childhood Fair skin, light hair, and light eye color that may increase susceptibility Presence of atypical moles or a large number of moles Family history of melanoma or other skin cancers Weakened immune system Older age, as the risk increases over time

Key Symptoms: A new or changing mole on the nose, often asymmetric with irregular borders Changes in color, including multiple shades or uneven pigmentation The appearance of a dark or black spot on the skin An open sore that doesn't heal A persistent lump or thickening on the nose Itching, tenderness, or pain confined to the lesion Bleeding or crusting over the affected area Swelling or redness around the lesion

Diagnostic & Treatment

Diagnosis Path: Diagnosis of malignant melanoma of the nose involves a thorough clinical examination by a healthcare professional, who will assess the lesion's appearance, size, and changes over time. A skin biopsy is essential to confirm the diagnosis — a small tissue sample is removed and examined microscopically. Additional tests like imaging studies (e.g., MRI, CT scans) may be used to determine if the cancer has spread to nearby tissues or other parts of the body. Regular skin examinations and monitoring are critical, particularly for individuals with multiple risk factors or a history of skin cancer.

Treatment Protocols: Treatment options generally focus on removing the cancerous tissue and preventing recurrence or spread. The primary approaches include: - Surgical excision: Complete removal of the tumor with some surrounding healthy tissue to ensure clear margins. - Mohs micrographic surgery: A precise surgical method that removes the cancer layer-by-layer, inspecting each layer until only cancer-free tissue remains, ideal for facial areas. - Sentinel lymph node biopsy: To check whether cancer has spread to nearby lymph nodes. - Adjuvant therapies: Such as immunotherapy, targeted therapy, or radiation therapy may be considered if the melanoma is advanced or metastasized. - Regular follow-ups: Ongoing monitoring to detect any recurrence early. Prognosis varies based on the tumor's thickness, location, and whether it has metastasized. Early diagnosis and treatment significantly improve the chances of successful management.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C43.31 a billable ICD-10 code?
Yes, C43.31 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C43.31?
Clinical documentation must specify the nature of Malignant melanoma of nose and any associated comorbidities for accurate reporting.

Cite this Clinical Reference